Impact BioMedical
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IBO and other ETFs, options, and stocks.About IBO
Impact BioMedical, Inc. is a holding company, which engages in the discovery and development of products and treatment options in specialty biopharmaceuticals and consumer healthcare. The firm focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases.
CEOFrank D. Heuszel
CEOFrank D. Heuszel
Employees2
Employees2
HeadquartersHouston, Texas
HeadquartersHouston, Texas
Founded2018
Founded2018
Employees2
Employees2
IBO Key Statistics
Market cap6.69M
Market cap6.69M
Price-Earnings ratio-0.17
Price-Earnings ratio-0.17
Dividend yield—
Dividend yield—
Average volume125.71K
Average volume125.71K
High today$0.5507
High today$0.5507
Low today$0.5338
Low today$0.5338
Open price$0.5444
Open price$0.5444
Volume59.59K
Volume59.59K
52 Week high$6.17
52 Week high$6.17
52 Week low$0.3621
52 Week low$0.3621
Stock Snapshot
The current Impact BioMedical(IBO) stock price is $0.55, with a market capitalization of 6.69M. The stock trades at a price-to-earnings (P/E) ratio of -0.17.
During the trading session on 2025-11-08, Impact BioMedical(IBO) shares reached a daily high of $0.55 and a low of $0.53. At a current price of $0.55, the stock is +3.0% higher than the low and still -0.1% under the high.
Trading volume for Impact BioMedical(IBO) stock has reached 59.59K, versus its average volume of 125.71K.
The stock's 52-week range extends from a low of $0.36 to a high of $6.17.
The stock's 52-week range extends from a low of $0.36 to a high of $6.17.
People also own
Based on the portfolios of people who own IBO. This list is generated using Robinhood data, and it’s not a recommendation.